A fireside chat with a Tamika D. Mallory will go down at sunset to inspire attendees. Powered by Novartis, Grow with Google, Chase for Business, and Barbados Tourism Marketing, the Pow(H)er Experience ...
The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...
The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...
Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...
Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...
Palla was also impressed by the firm’s client roster. She noted that White & Case has worked with significant life sciences ...
Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...
Gabriele Ricci, chief data and technology officer, has been reorganizing the technology function at Takeda Pharmaceutical.
Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback